4153F Combo pegintf/rib prescription
Also known as: peginterferon ribavirin measure, HCV combination therapy measure, Hepatitis C combination measure
Performance measure code indicating that combination pegylated interferon and ribavirin therapy was prescribed or recommended.
In Plain Language
Hepatitis C combination medication; interferon and ribavirin therapy; HCV treatment combination
Clinical Context
Quality measure tracking use of combination pegylated interferon and ribavirin therapy for Hepatitis C. Now largely replaced by direct-acting antivirals.
RVU Information
CPT 4153F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4153F?
CPT 4153F (Combo pegintf/rib prescription) is a Other code. Performance measure code indicating that combination pegylated interferon and ribavirin therapy was prescribed or recommended.
Who uses CPT code 4153F?
CPT 4153F is used by Infectious Disease, Gastroenterology, Hepatology. Quality measure tracking use of combination pegylated interferon and ribavirin therapy for Hepatitis C. Now largely replaced by direct-acting antivirals.
When is CPT 4153F used?
Quality measure tracking use of combination pegylated interferon and ribavirin therapy for Hepatitis C. Now largely replaced by direct-acting antivirals.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.